Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3718-3718
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽
2016 ◽
Vol 21
(4)
◽
pp. 705-712
◽